60
Participants
Start Date
February 1, 2019
Primary Completion Date
August 19, 2024
Study Completion Date
August 19, 2024
repetitive transcranial magnetic stimulation (rTMS)
A rTMS system is an electromagnetic device that non-invasively delivers a rapidly pulsed magnetic field to the cerebral cortex in order to activate neurons within a limited volume without inducing a seizure. The device is intended to be used to treat patients meeting clinical criteria for MDD as defined in the Diagnostic and Statistical Manual of Mental Illnesses, Fourth Edition (DSM-IV). This guidance is issued in conjunction with a Federal Register notice announcing the classification of rTMS systems for the treatment of MDD.
Semel Institute of Neuroscience, Los Angeles
National Institutes of Health (NIH)
NIH
National Institute on Drug Abuse (NIDA)
NIH
Food and Drug Administration (FDA)
FED
University of California, Los Angeles
OTHER